Tower Research Capital »

Calidi Biotherapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2k 2.8k 1.17

More positions owned by Tower Research Capital

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SJNK)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Ishares Tr Russell 2000 Etf (IWM)
Advanced Micro Devices (AMD)
Wisdomtree Tr Floatng Rat Trea (USFR)
JPMorgan Chase & Co. (JPM)

View all positions for Tower Research Capital

Top funds holding Calidi Biotherapeutics

DRW Holdings
HighTower Advisors
Geode Capital Management
Vanguard Group
Virtu Financial
Rs Crum
Belpointe Asset Management
Northern Trust
Jane Street
Farther Finance Advisors
UBS Group
Tower Research Capital
Advisor Group Holdings
Finepoint Capital
Apollo Management Holdings

View all funds holding Calidi Biotherapeutics